A Phase 3 interventional study of Vitamin D in Sarcopenia, sponsored by Sengkang General Hospital. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.
Sponsored by Sengkang General Hospital · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Vitamin D plays a significant part calcium and phosphate haemostasis, thus, intrinsically critical for bone health. Increasing evidence also reveal that insufficient serum vitamin D levels also result in poor muscle health with such individuals having a compromised muscle building potential (4 times slower muscle building).
Muscle health is a critical component of a post-surgical patient recovery, with impaired muscle function leading to reduced functional ability, resulting in a poorer quality of life. Poor muscle health also has negative repercussion on survivability, with reduced overall, and disease-specific survival, especially shown in cancer patients. Thus, maintenance of vitamin D levels post-surgery may be more critical than previously thought.
This study is performed in Singapore (outside the US) and the medication, while it is a FDA approved medication, is not manufactured in the US for the trial purpose and the indications of use in this trial is not new.
The investigators would be recruiting patients aged 21-65 years who have undergone major surgery (defined by the NICE criteria) and who are able to provide informed consent, accept to take vitamin D supplements post-operatively and have their serum vitamin D levels checked periodically.
The investigators will excluded patients who have undergone minor procedures (Table code \<4a), those who have a history of chronic kidney disease/end staged renal failure, known hyperparathyroidism, are non-ambulatory independently and have had known allergies to the commercially available high dose vitamin D formulations.
High dose oral vitamin D supplementation (50,000 IU/week for 8 weeks) is the current recommended dose for individuals with vitamin D insufficiency of deficiency and is currently being used for some prehabilitation programmes due to the quick repletion of vitamin D levels to improve muscle gain during the short prehabilitation window prior to surgery.
Using the same dose once a month would provide a significantly less vitamin D supplementation, especially with individuals who have had their vitamin D levels repleted in the preoperative phase. This will be compared against a control who are randomised to standard-of-care (SOC) where high dose vitamin D maintenance is not prescribed.
The unmet clinical need is the still unknown, unstandardised vitamin D supplementation regime. There are current no clinical consensus on vitamin D supplementation after patients who have undergone major surgery.
1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.
This study's planned enrollment of 100 is above the median of 60 across 860 interventional studies indexed under Sarcopenia.
Browse Sarcopenia studies →Sengkang General Hospital is the lead sponsor of 16 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
High dose oral vitamin D supplementation (50,000 IU/once a month)
Drug: Vitamin D
standard of care arm where vitamin D levels are not actively acted upon
High dose oral vitamin D supplementation (50,000 IU/once per month)
Also known as: D-cure
serum 25-hydroxyvitamin D levels at 3-months post-intervention
serum 25-hydroxyvitamin D levels at 3-months post-intervention
Time frame: 3 months after initiation
serum 25-hydroxyvitamin D levels compared to SOC at 6-months post-intervention.
serum 25-hydroxyvitamin D levels compared to SOC at 6-months post-intervention.
Time frame: 6 months after initiation
serum 25-hydroxyvitamin D levels compared to SOC at 12-months post-intervention.
serum 25-hydroxyvitamin D levels compared to SOC at 12-months post-intervention.
Time frame: 12 months after initiation
functional outcome measures at 3-months post-intervention
functional outcome measures at 3-months post-intervention
Time frame: 3-months after intiation
functional outcome measures at 6-months post-intervention
functional outcome measures at 6-months post-intervention
Time frame: 6 months after initiation
functional outcome measures at 12-months post-intervention
functional outcome measures at 12-months post-intervention
Time frame: 12 months after initiation
muscle quality (Ultrasound+MuscleSound™ evaluation) at 3-months post-intervention
muscle quality (Ultrasound+MuscleSound™ evaluation) at 3-months post-intervention
Time frame: 3 months after intiation
muscle quality (Ultrasound+MuscleSound™ evaluation) at 6-months post-intervention
muscle quality (Ultrasound+MuscleSound™ evaluation) at 6-months post-intervention
Time frame: 6 months after initiation
muscle quality (Ultrasound+MuscleSound™ evaluation) at 12-months post-intervention
muscle quality (Ultrasound+MuscleSound™ evaluation) at 12-months post-intervention
Time frame: 12 months after initiation
quality of life (EQ5D-3L) at 3-months post-intervention
quality of life (EQ5D-3L) at 3-months post-intervention
Time frame: 3 months after intiation
quality of life (EQ5D-3L) at 6-months post-intervention
quality of life (EQ5D-3L) at 6-months post-intervention
Time frame: 6 months after initiation
quality of life (EQ5D-3L) at 12-months post-intervention
quality of life (EQ5D-3L) at 12-months post-intervention
Time frame: 12 months after initiation
Plan to share: No — only centrally available to the PI
Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Vitamin D
Sengkang General Hospital